Statutory Instruments
2015 No. 232
Dangerous Drugs, England And Wales
Dangerous Drugs, Scotland
The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2015
Made 12th February 2015
Laid before Parliament 18th February 2015
Coming into force 11th March 2015

The Secretary of State, in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971, and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, makes the following Order:
1971 c. 38.

Citation, commencement and extent
1. (1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2015 and comes into force on 11th March 2015.
(2) This Order extends to England and Wales and Scotland.

Amendment to the Misuse of Drugs (Designation) Order 2001
2. (1) The Misuse of Drugs (Designation) Order 2001 is amended as follows.
S.I. 2001/3997 as amended by S.I. 2005/1652, S.I. 2009/3135, S.I. 2010/1143, S.I. 2010/1800, S.I. 2011/447, S.I. 2012/1310, S.I. 2013/177, S.I. 2013/624, S.I. 2014/1274, S.I. 2014/1376 and S.I. 2014/3276.
(2) In paragraph 1(a) of Part 1 of the Schedule—
(a) after “4-Bromo-2,5-dimethoxy-a-methylphenethylamine” insert—

“1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)”;

(b) after “4-Methyl-aminorex” insert—

“4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)”.

Lynne Featherstone
Minister of State
Home Office
12th February 2015

EXPLANATORY NOTE
(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order 2001 by inserting a potent opoid known as MT-45 and a synthetic stimulant known as 4,4’-DMAR into Part 1 of the Schedule to that Order.
A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.